Description
The Beta 2 Glycoprotein 1 IgA Antibody (Serum) test measures the specific IgA class of autoantibodies directed against the β2GP1 protein. This specialized diagnostic tool is primarily used to evaluate the risk of abnormal blood clotting and recurrent pregnancy loss associated with Antiphospholipid Syndrome (APS), especially when standard IgG and IgM test results return negative but clinical suspicion remains high.
What is the Beta 2 Glycoprotein 1 IgA Antibody Test?
Beta-2 Glycoprotein 1 is a blood protein that binds to lipids on cell membranes. In patients with Antiphospholipid Syndrome (APS), the immune system mistakenly produces autoantibodies that attack this protein, leading to an increased risk of dangerous blood clots (thrombosis) in arteries and veins.
While IgG and IgM are the most frequently tested antibody classes for APS, the IgA isotype is a crucial secondary marker. Detecting IgA antibodies provides doctors with a more comprehensive autoimmune profile, ensuring that patients who carry this specific antibody class do not go undiagnosed.
Why is This Test Ordered?
Your rheumatologist or physician may recommend this specific test if you are presenting with symptoms of a clotting disorder, but initial screening tests have been inconclusive. Common reasons for testing include:
- Unexplained Thrombosis: A history of deep vein thrombosis (DVT), pulmonary embolism, stroke, or heart attacks without typical risk factors.
- Obstetric Complications: Investigating recurrent unexplained miscarriages, premature births, or severe preeclampsia.
- Inconclusive APS Screening: When a patient exhibits strong clinical signs of APS, but Lupus Anticoagulant, Anti-Cardiolipin, and Beta-2 Glycoprotein IgG/IgM tests are negative.
- Comprehensive Autoimmune Workup: Monitoring systemic autoimmune diseases like Systemic Lupus Erythematosus (SLE).
